The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Saturday approved Arcturus Therapeutics’s Kostaive (zapomeran, ARCT-154) self-amplifying sa-mRNA COVID-19 vaccine for individuals aged 18 years and older. 

Governments are not only ignoring concerns about mRNA injections but are authorising enhanced versions of these genetic products despite limited long-term safety data and unresolved questions about duration, biodistribution, and immune effects. [Read More]